Thyroid Stimulating Hormone Receptor Antibody (TRAb)
The thyroid gland is a small gland located in the front of the neck. It converts iodine and the amino acid tyrosine into the thyroid hormones thyroxine (T4) and triiodothyronine (T3). These hormones function mainly to regulate metabolism and to regulate growth and development.
The thyroid-stimulating hormone receptor (TSH-R) is a G protein-linked, 7-transmembrane domain receptor. It is the primary antigen in autoimmune thyroid disease. This test detects heterogeneous IgG antibodies directed against the TSH receptor on thyroid cells. The test measures antibody indirectly by the stimulation of adenylyl cyclase to produce cAMP. Although TSH-R antibody is a marker of Graves disease, the test is not necessary for the diagnosis in most cases. TSH-R antibody is very rarely indicated, but may be helpful in pregnant women with a history of Graves disease. This is because TSH-R antibody may have some predictive value for neonatal thyrotoxicosis. TSH-R antibody may also be indicated for patients with symptoms consistent with Graves disease to confirm the diagnosis.
High titers of TSH-R antibody are associated with relapse of hyperthyroidism at the end of a course of antithyroid drugs.
- Diagnosis of Graves disease in a euthyroid patient
- Differential diagnosis of Graves disease and toxic goiter
- Evaluating risk of neonatal thyrotoxicosis in fetus of mother with Graves disease or history of Graves disease
- Therapy monitoring
- Differential diagnosis of thyrotoxicosis in a patient with nonspecific symptoms and/or nondiagnostic or contraindicated thyroid scan
- Differentiating first onset of or recurrence of Graves disease versus gestational thyrotoxicosis
- Assessing chance of Graves relapse following drug therapy
Increased in:
- Autoimmune thyroiditis
- Graves disease
- Transient neonatal thyrotoxicosis
- Hashimoto's thyrotoxicosis
- Nonspecific goiter
<130% of basal activity
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST).
Stability
- Ambient: 1-3 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Endocrinol Metab Clin North Am. 2000;29:339. [PMID: 10874533]
- Horm Metab Res. 2005;37:745. [PMID: 16372228]
- Horm Metab Res. 2005;37:741. [PMID: 16372227]
- J Clin Invest. 2005;115:1972. [PMID: 16075037]
- Treat Endocrinol. 2005;4:31. [PMID: 15649099]
- Starrenburg-Razenberg AJ, Castro Cabezas M, Gan IM, Njo TL, Rietveld AP, Elte JW. Four patients with hypothyroid Graves' disease. Neth J Med. 2010 Apr;68(4):178-80.
- Bishop ML, Duben-Engelkirk JL, Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott (1996).